GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 17.18
(0.41%)
CNY 17.18
(0.41%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.12 Billion CNY | 12.54% |
| 2022 | 995.69 Million CNY | 3.54% |
| 2021 | 961.65 Million CNY | -27.6% |
| 2020 | 1.32 Billion CNY | 21.24% |
| 2019 | 1.09 Billion CNY | 51.6% |
| 2018 | 722.67 Million CNY | 34.45% |
| 2017 | 537.49 Million CNY | 29.95% |
| 2016 | 413.6 Million CNY | 25.6% |
| 2015 | 329.3 Million CNY | -12.55% |
| 2014 | 376.56 Million CNY | -16.78% |
| 2013 | 452.47 Million CNY | -32.44% |
| 2012 | 669.71 Million CNY | -54.45% |
| 2011 | 1.47 Billion CNY | -27.93% |
| 2010 | 2.04 Billion CNY | -6.29% |
| 2009 | 2.17 Billion CNY | -0.95% |
| 2008 | 2.19 Billion CNY | -17.39% |
| 2007 | 2.66 Billion CNY | 33.71% |
| 2006 | 1.99 Billion CNY | 6.82% |
| 2005 | 1.86 Billion CNY | 8.15% |
| 2004 | 1.72 Billion CNY | -0.07% |
| 2003 | 1.72 Billion CNY | 122.78% |
| 2002 | 773.84 Million CNY | 22.6% |
| 2001 | 631.18 Million CNY | 69.0% |
| 2000 | 373.48 Million CNY | 190.04% |
| 1999 | 128.77 Million CNY | -18.12% |
| 1998 | 157.26 Million CNY | 0.42% |
| 1997 | 156.6 Million CNY | 104.51% |
| 1996 | 76.57 Million CNY | 17.88% |
| 1995 | 64.95 Million CNY | 53.46% |
| 1994 | 42.32 Million CNY | 70.32% |
| 1993 | 24.85 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 814.55 Million CNY | 2.91% |
| 2024 Q2 | 791.52 Million CNY | -24.49% |
| 2024 Q1 | 1.04 Billion CNY | -6.46% |
| 2023 FY | 1.12 Billion CNY | 12.54% |
| 2023 Q3 | 797.16 Million CNY | -16.51% |
| 2023 Q1 | 1.01 Billion CNY | 1.88% |
| 2023 Q4 | 1.12 Billion CNY | 40.57% |
| 2023 Q2 | 954.74 Million CNY | -5.88% |
| 2022 Q3 | 916.42 Million CNY | -3.83% |
| 2022 FY | 995.69 Million CNY | 3.54% |
| 2022 Q1 | 952.51 Million CNY | -0.95% |
| 2022 Q2 | 952.94 Million CNY | 0.04% |
| 2022 Q4 | 995.69 Million CNY | 8.65% |
| 2021 Q3 | 975.32 Million CNY | -5.89% |
| 2021 Q1 | 1.13 Billion CNY | -14.64% |
| 2021 FY | 961.65 Million CNY | -27.6% |
| 2021 Q4 | 961.65 Million CNY | -1.4% |
| 2021 Q2 | 1.03 Billion CNY | -8.59% |
| 2020 Q2 | 1.35 Billion CNY | 9.09% |
| 2020 Q3 | 1.39 Billion CNY | 3.34% |
| 2020 Q4 | 1.32 Billion CNY | -5.08% |
| 2020 Q1 | 1.24 Billion CNY | 13.31% |
| 2020 FY | 1.32 Billion CNY | 21.24% |
| 2019 Q1 | 637.05 Million CNY | -11.85% |
| 2019 Q2 | 798.51 Million CNY | 25.35% |
| 2019 Q4 | 1.09 Billion CNY | 22.87% |
| 2019 FY | 1.09 Billion CNY | 51.6% |
| 2019 Q3 | 891.62 Million CNY | 11.66% |
| 2018 Q4 | 722.67 Million CNY | 42.2% |
| 2018 FY | 722.67 Million CNY | 34.45% |
| 2018 Q3 | 508.21 Million CNY | 10.96% |
| 2018 Q1 | 493.66 Million CNY | -8.15% |
| 2018 Q2 | 458.02 Million CNY | -7.22% |
| 2017 Q4 | 537.49 Million CNY | 50.47% |
| 2017 FY | 537.49 Million CNY | 29.95% |
| 2017 Q3 | 357.21 Million CNY | 3.97% |
| 2017 Q2 | 343.56 Million CNY | 6.13% |
| 2017 Q1 | 323.73 Million CNY | -21.73% |
| 2016 Q1 | 327.92 Million CNY | -0.42% |
| 2016 Q4 | 413.6 Million CNY | 18.32% |
| 2016 FY | 413.6 Million CNY | 25.6% |
| 2016 Q2 | 319.27 Million CNY | -2.64% |
| 2016 Q3 | 349.54 Million CNY | 9.48% |
| 2015 FY | 329.3 Million CNY | -12.55% |
| 2015 Q2 | 407.7 Million CNY | 4.53% |
| 2015 Q4 | 329.3 Million CNY | -17.22% |
| 2015 Q3 | 397.8 Million CNY | -2.43% |
| 2015 Q1 | 390.03 Million CNY | 3.58% |
| 2014 FY | 376.56 Million CNY | -16.78% |
| 2014 Q1 | 446.68 Million CNY | -1.28% |
| 2014 Q4 | 376.56 Million CNY | -27.31% |
| 2014 Q2 | 457.47 Million CNY | 2.41% |
| 2014 Q3 | 518.02 Million CNY | 13.24% |
| 2013 Q3 | 415.91 Million CNY | -2.59% |
| 2013 Q4 | 452.47 Million CNY | 8.79% |
| 2013 Q1 | 530.4 Million CNY | -20.8% |
| 2013 FY | 452.47 Million CNY | -32.44% |
| 2013 Q2 | 426.95 Million CNY | -19.5% |
| 2012 FY | 669.71 Million CNY | -54.45% |
| 2012 Q4 | 669.71 Million CNY | -55.89% |
| 2012 Q3 | 1.51 Billion CNY | 0.87% |
| 2012 Q2 | 1.5 Billion CNY | 1.07% |
| 2012 Q1 | 1.48 Billion CNY | 1.28% |
| 2011 Q1 | 1.87 Billion CNY | -7.91% |
| 2011 Q2 | 1.58 Billion CNY | -15.52% |
| 2011 Q3 | 1.41 Billion CNY | -10.55% |
| 2011 Q4 | 1.47 Billion CNY | 3.56% |
| 2011 FY | 1.47 Billion CNY | -27.93% |
| 2010 Q2 | 2.13 Billion CNY | -3.12% |
| 2010 FY | 2.04 Billion CNY | -6.29% |
| 2010 Q1 | 2.2 Billion CNY | 1.21% |
| 2010 Q4 | 2.04 Billion CNY | -6.39% |
| 2010 Q3 | 2.17 Billion CNY | 2.09% |
| 2009 Q1 | 2.18 Billion CNY | -0.4% |
| 2009 Q3 | 2.19 Billion CNY | 1.7% |
| 2009 Q4 | 2.17 Billion CNY | -0.71% |
| 2009 Q2 | 2.15 Billion CNY | -1.51% |
| 2009 FY | 2.17 Billion CNY | -0.95% |
| 2008 Q1 | 2.59 Billion CNY | -2.51% |
| 2008 Q3 | 2.06 Billion CNY | -19.5% |
| 2008 Q4 | 2.19 Billion CNY | 6.26% |
| 2008 FY | 2.19 Billion CNY | -17.39% |
| 2008 Q2 | 2.56 Billion CNY | -0.95% |
| 2007 Q2 | 2.13 Billion CNY | -1.14% |
| 2007 Q4 | 2.66 Billion CNY | 31.55% |
| 2007 FY | 2.66 Billion CNY | 33.71% |
| 2007 Q1 | 2.16 Billion CNY | 8.61% |
| 2007 Q3 | 2.02 Billion CNY | -5.35% |
| 2006 FY | 1.99 Billion CNY | 6.82% |
| 2006 Q1 | 950.63 Million CNY | -48.97% |
| 2006 Q4 | 1.99 Billion CNY | -2.49% |
| 2006 Q3 | 2.04 Billion CNY | 115.98% |
| 2006 Q2 | 944.97 Million CNY | -0.6% |
| 2005 Q3 | 991.79 Million CNY | -14.6% |
| 2005 Q2 | 1.16 Billion CNY | 17.05% |
| 2005 Q1 | 992.23 Million CNY | -42.4% |
| 2005 FY | 1.86 Billion CNY | 8.15% |
| 2005 Q4 | 1.86 Billion CNY | 87.85% |
| 2004 FY | 1.72 Billion CNY | -0.07% |
| 2004 Q1 | 979.74 Million CNY | -43.17% |
| 2004 Q3 | 892.23 Million CNY | -1.9% |
| 2004 Q4 | 1.72 Billion CNY | 93.08% |
| 2004 Q2 | 909.52 Million CNY | -7.17% |
| 2003 FY | 1.72 Billion CNY | 122.78% |
| 2003 Q1 | 798 Million CNY | 3.12% |
| 2003 Q2 | 822.22 Million CNY | 3.04% |
| 2003 Q3 | 851.85 Million CNY | 3.6% |
| 2003 Q4 | 1.72 Billion CNY | 102.38% |
| 2002 FY | 773.84 Million CNY | 22.6% |
| 2002 Q1 | 638.77 Million CNY | 1.2% |
| 2002 Q2 | 650.08 Million CNY | 1.77% |
| 2002 Q3 | 747.89 Million CNY | 15.05% |
| 2002 Q4 | 773.84 Million CNY | 3.47% |
| 2001 Q2 | 499.23 Million CNY | 0.0% |
| 2001 FY | 631.18 Million CNY | 69.0% |
| 2001 Q4 | 631.18 Million CNY | 0.0% |
| 2000 Q2 | 124.2 Million CNY | 0.0% |
| 2000 Q4 | 373.48 Million CNY | 0.0% |
| 2000 FY | 373.48 Million CNY | 190.04% |
| 1999 FY | 128.77 Million CNY | -18.12% |
| 1999 Q2 | 137.47 Million CNY | 0.0% |
| 1999 Q4 | 128.77 Million CNY | 0.0% |
| 1998 FY | 157.26 Million CNY | 0.42% |
| 1998 Q4 | 157.26 Million CNY | 0.0% |
| 1998 Q2 | 180.24 Million CNY | 0.0% |
| 1997 Q2 | 77.51 Million CNY | 0.0% |
| 1997 FY | 156.6 Million CNY | 104.51% |
| 1997 Q4 | 156.6 Million CNY | 0.0% |
| 1996 Q4 | 76.57 Million CNY | 0.0% |
| 1996 FY | 76.57 Million CNY | 17.88% |
| 1995 FY | 64.95 Million CNY | 53.46% |
| 1994 FY | 42.32 Million CNY | 70.32% |
| 1993 FY | 24.85 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 2.75 Billion CNY | 59.274% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.14 Billion CNY | 64.339% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.88 Billion CNY | 71.184% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 887.5 Million CNY | -26.258% |
| Aurora Optoelectronics Co.,Ltd. | 1.09 Billion CNY | -1.886% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 290.34 Million CNY | -285.944% |
| NanJing Pharmaceutical Company Limited | 20.95 Billion CNY | 94.653% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 527.57 Million CNY | -112.397% |